Boston Scientific Corp. (henceforth "Defendant"), a developer & manufacturer of medical devices, in November 2014, was ordered to pay four women over $26 million after a Miami federal court jury found that it was liable for marketing faulty Transvaginal mesh devices.
According to Thompson Reuters, the Plaintiffs sustained bleeding, pain, and infection as a result of the company's Pinnacle device, which was developed to treat pelvic organ prolapse and stress urinary incontinence. Although the Defendant was ordered to pay $26.7 million in compensatory damages, it will not face additional punitive damages. Each Plaintiff in the case is receiving between $6.5 million and $6.7 million.
The Defendant is currently facing beyond 14,000 federal lawsuits over its mesh devices.
In the last 3 months, Neural IT's Voice Processing division has been highly successful in converting leads for clients. Out of 1,361 possible contacts, the Voice Processing team was able to convert 30.5% or 416 contacts.
In the Transvaginal Mesh litigation space, Neural IT has had 1,630 medical record requests from firms, out of which 860 were reviewed for evidence. Of those records, our physicians found evidence in 453 that identified the product used in a given case, for a conversation rate of 52.67%.